Search by property

Jump to navigation Jump to search

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

Search by property

A list of all pages that have property "AnswerE" with value "Increase in hospitalizations and no effect on overall mortality". Since there have been only a few results, also nearby values are displayed.

Showing below up to 26 results starting with #1.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)


    

List of results

  • WBR0853  + (I.V Ciprofloxacin for 4-6 weeks)
  • WBR0962  + (I.V glucocorticoids)
  • WBR0680  + (IL-10)
  • WBR0141  + (IL-8)
  • WBR1090  + (IV glucagon)
  • WBR0378  + (IV normal saline)
  • WBR0019  + (Idiopathic)
  • WBR0030  + (Idiopathic)
  • WBR0874  + (Idiopathic pulmonary fibrosis)
  • WBR0872  + (IgA deposits)
  • WBR0476  + (IgE antibodies against hemidesmosomes)
  • WBR1044  + (IgM Antibodies to dermal epidermal junction)
  • WBR0828  + (Immediately administer a bolus of 15 grams of 50% dextrose)
  • WBR291  + (Immotile on wet mount)
  • WBR0703  + (Immune complexes)
  • WBR0374  + (Immune modulation by interleukin-2 recombinant therapy)
  • WBR0218  + (Imprinting)
  • WBR0436  + (Imprinting)
  • WBR0328  + (Inability to swallow)
  • WBR0054  + (Inactivation of elongation factor-2)
  • WBR284  + (Inadequate migration of neural crest cells)
  • WBR1055  + (Increase albuterol dose)
  • WBR0615  + (Increase in acetylcholine)
  • WBR0580  + (Increase in arterial pCO2 and decrease in arterial pO2)
  • WBR0949  + (Increase in carbon monoxide (CO))
  • WBR0192  + (Increase in hospitalizations and no effect on overall mortality)
  • WBR0732  + (Increase in insulin sensitivity)
  • WBR0860  + (Increase in proton gradient across electron transport chain)
  • WBR0055  + (Increase of cAMP by intrinsic enzymatic activity)
  • WBR0369  + (Increased norepinephrine, Decreased GABA, Decreased serotonin)
  • WBR0864  + (Increased residual volume)
  • WBR0877  + (Increased urinary NGAL (neutrophil gelatinase-associated lipocalin))
  • WBR1106  + (Increases G<sub>q</sub> activity)
  • WBR0291  + (Increases the concentration of cyclic AMP (cAMP) via calmodulin-activated adenylyl cyclase activity.)
  • WBR0047  + (India ink)
  • WBR0224  + (Inferior petrosal sinus sampling.)
  • WBR0101  + (Infertility)
  • WBR0175  + (Inflammation of the entire small and large bowels.)
  • WBR0044  + (Influenza virus)
  • WBR0161  + (Inherited disorder characterized by substitution of glutamic acid with valine)
  • WBR0434  + (Inhibition of DNA polymerase activity)
  • WBR0536  + (Inhibition of GABA reuptake)
  • WBR0487  + (Inhibition of protein kinase)
  • WBR0349  + (Inhibition of thromboxane A2 production)
  • WBR0235  + (Inhibitor of aminoacyl tRNA entry into ribosome)
  • WBR0252  + (Inhibits DNA gyrase)
  • WBR0056  + (Inhibits cell wall synthesis by binding and inactivating proteins)
  • WBR0478  + (Inhibits ergosterol synthesis)
  • WBR0157  + (Inhibits hypoxanthine-guanine phosphoribosyltransferase)
  • WBR0507  + (Inhibits protein elongation by blocking peptidyl-transferase)
  • WBR0306  + (Initiate HAART and trimethoprim-sulphamethoxazole)